Company registration number 15231923 (England and Wales)
BERKSHIRE HEALTH GROUP LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
BERKSHIRE HEALTH GROUP LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2
Notes to the financial statements
3 - 6
BERKSHIRE HEALTH GROUP LIMITED
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF BERKSHIRE HEALTH GROUP LIMITED FOR THE YEAR ENDED 31 DECEMBER 2025
- 1 -
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Berkshire Health Group Limited for the year ended 31 December 2025 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.
This report is made solely to the board of directors of Berkshire Health Group Limited, as a body, in accordance with the terms of the engagement letter dated 30 September 2024. Our work has been undertaken solely to prepare for your approval the financial statements of Berkshire Health Group Limited and state those matters that we have agreed to state to the board of directors of Berkshire Health Group Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Berkshire Health Group Limited and its board of directors as a body, for our work or for this report.
It is your duty to ensure that Berkshire Health Group Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Berkshire Health Group Limited. You consider that Berkshire Health Group Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Berkshire Health Group Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Beavis Morgan LLP
Accountants, Business and Tax Advisers
18 September 2026
82 St John Street
London
EC1M 4JN
BERKSHIRE HEALTH GROUP LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
4
540,772
36,177
Current assets
Debtors
5
12,512
121,285
Cash at bank and in hand
4,796
9,872
17,308
131,157
Creditors: amounts falling due within one year
6
(686,419)
(224,172)
Net current liabilities
(669,111)
(93,015)
Net liabilities
(128,339)
(56,838)
Capital and reserves
Called up share capital
7
105
100
Share premium account
250,495
Profit and loss reserves
(378,939)
(56,938)
Total equity
(128,339)
(56,838)
For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 17 September 2026 and are signed on its behalf by:
Mr J J Alberto
Director
Company registration number 15231923 (England and Wales)
BERKSHIRE HEALTH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information
Berkshire Health Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is Lillibrooke Manor, Ockwells Road, Maidenhead, Berkshire, SL6 3LP.
1.1
Reporting period
The financial statements for the previous accounting period were prepared for the period from 24 October 2023 to 31 December 2024 and therefore the comparative amounts presented in the financial statements (including the related notes) are not entirely comparable.
1.2
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting
Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.3
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.4
Revenue
Turnover comprises amounts receivable for services provided in the normal course of business, exclusive of VAT and after deduction of trade discounts. Turnover is recognized in line with delivery of service. Turnover is entirely attributable to the Company's principal activities.
1.5
Fixed asset investments
Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.6
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with bank.
BERKSHIRE HEALTH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.7
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors and loan from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.9
Employee benefits
The costs of short-term employee benefits are recognized as a liability and an expense.
The cost of any unused holiday entitlement is recognized in the period in which the employee's services are received.
BERKSHIRE HEALTH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
6
4
4
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
540,772
36,177
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 1 January 2025
36,177
Additions
504,595
At 31 December 2025
540,772
Carrying amount
At 31 December 2025
540,772
At 31 December 2024
36,177
BERKSHIRE HEALTH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
6,000
3,000
Amounts owed by group undertakings
93,379
Other debtors
6,512
24,906
12,512
121,285
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
1,386
Amounts owed to group undertakings
572,598
Taxation and social security
5,960
2,713
Other creditors
106,475
221,459
686,419
224,172
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 0.0001 each
1,052,800
100
105
100
On 25 November 2025, 100 Ordinary shares of £1 each were sub-divided into 1,000,000 Ordinary shares of £0.0001 each.
On 25 November 2025, 52,800 Ordinary shares of £0.0001 each were issued and fully paid for a total consideration of £250,500.
8
Directors' transactions
Included within other creditors is an amount of £1,477 (2024: £218,709) owed to the directors. The loan is interest free and repayable on demand.